Randomized Controlled Trial for Exparel Hip Fracture
Completed · Phase 4
Conditions studied: Hip Fractures
In brief
This is a prospective, randomized study looking at the effect that a long-acting local anesthetic has on pain control in patients having surgery for hip fractures. The investigators are conducting the study to see if that reduces the amount of pain medicine needed after surgery, and if it reduces other medical complications after surgery.
Key facts
- Study ID
- NCT03289858
- Run by
- University of Massachusetts, Worcester
- People needed
- 55
- Starts
- 2017-09-01
- Expected to finish
- 2019-01-22
- Last updated by the study team
- 2021-03-18
Who can join
Age: 55 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age 55 or older
- Sustaining either an OTA/AO type 31A or 31B fracture undergoing ORIF or hemiarthroplasty
- Able to consent
- Isolated injury
You may not qualify if…
- OTA/AO 31B1 (Impacted/slightly displaced)
- Baseline dementia or cognitive deficit
- Inability to consent
- Chronic Opioid use
- End stage liver disease with Model for End-Stage Liver Disease (MELD) greater than 20.
- End stage renal disease as defined by patients requiring hemodialysis at least twice weekly
- Polytrauma, defined as: concurrent upper or lower extremity fracture, pelvis fracture, spine fracture, rib fractures, or facial fractures, Blunt chest or abdominal trauma resulting in diagnosed organ injury, Head trauma resulting in intracranial bleed or diagnosed concussion
- Allergy to amide-type local anesthetics
- Prisoners (unlikely to be accessible for follow-up)
Where it is running
- University of Kentucky — Lexington, Kentucky, United States
- UMass Memorial Medical Center — Worcester, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.